XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
3 Months Ended
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (3,822,859) $ (5,356,619)
Adjustments to reconcile net loss to net cash (used in) operating activities    
Depreciation and amortization 103,160 41,672
Stock based compensation- stock option grants 744,640 204,170
Right of use, net (1,328) (1,781)
Interest expense for extension of notes and warrants 206,994 0
Amortization of debt discount to interest expense 0 4,184,657
Changes in operating assets and liabilities:    
Other long-term assets (1,998) 0
Accounts receivable-related party 0 (3,124,581)
Accounts payable - trade and accrued expenses (146,026)  
NET CASH (USED IN) OPERATING ACTIVITIES (2,917,417) (1,907,817)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of research and development equipment (10,846) (385,488)
NET CASH (USED IN) INVESTING ACTIVITIES: (10,846) (385,488)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock for stock options exercise 2,343 2,344
Proceeds from issuance of common stock for warrant exercise 12,500 766,486
NET CASH PROVIDED BY FINANCING ACTIVITIES 14,843 768,830
NET (DECREASE) IN CASH AND CASH EQUIVALENTS (2,913,420) (1,524,475)
CASH AND CASH EQUIVALENTS, beginning of period 12,593,692 12,258,218
CASH AND CASH EQUIVALENTS, end of period 9,680,272 10,733,743
Supplemental disclosures of cash flow information:    
Interest paid 0 0
Taxes paid $ 0 $ 0